These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16892225)

  • 1. Using budding yeast to screen for anti-prion drugs.
    Tribouillard D; Bach S; Gug F; Desban N; Beringue V; Andrieu T; Dormont D; Galons H; Laude H; Vilette D; Blondel M
    Biotechnol J; 2006 Jan; 1(1):58-67. PubMed ID: 16892225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A yeast-based assay to isolate drugs active against mammalian prions.
    Bach S; Tribouillard D; Talarek N; Desban N; Gug F; Galons H; Blondel M
    Methods; 2006 May; 39(1):72-7. PubMed ID: 16750390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of drugs active against mammalian prions using a yeast-based screening assay.
    Bach S; Talarek N; Andrieu T; Vierfond JM; Mettey Y; Galons H; Dormont D; Meijer L; Cullin C; Blondel M
    Nat Biotechnol; 2003 Sep; 21(9):1075-81. PubMed ID: 12910243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion].
    Ishikawa T
    Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
    Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
    Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of budding yeast prion-determinant sequences across diverse fungi.
    Harrison LB; Yu Z; Stajich JE; Dietrich FS; Harrison PM
    J Mol Biol; 2007 Apr; 368(1):273-82. PubMed ID: 17320905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageing in yeast does not enhance prion generation.
    Shewmaker F; Wickner RB
    Yeast; 2006 Dec; 23(16):1123-8. PubMed ID: 17133618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid oligomers: diffuse oligomer-based transmission of yeast prions.
    Taguchi H; Kawai-Noma S
    FEBS J; 2010 Mar; 277(6):1359-68. PubMed ID: 20148963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical basis of how prion conformations determine strain phenotypes.
    Tanaka M; Collins SR; Toyama BH; Weissman JS
    Nature; 2006 Aug; 442(7102):585-9. PubMed ID: 16810177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The [URE3] prion is not conserved among Saccharomyces species.
    Talarek N; Maillet L; Cullin C; Aigle M
    Genetics; 2005 Sep; 171(1):23-34. PubMed ID: 15956663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prions of yeast fail to elicit a transcriptional response.
    Ross ED; Wickner RB
    Yeast; 2004 Aug; 21(11):963-72. PubMed ID: 15334559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the Hsp70 ATPase domain in yeast prion propagation.
    Loovers HM; Guinan E; Jones GW
    Genetics; 2007 Feb; 175(2):621-30. PubMed ID: 17151238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly identified prions in budding yeast, and their possible functions.
    Crow ET; Li L
    Semin Cell Dev Biol; 2011 Jul; 22(5):452-9. PubMed ID: 21397710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporter assay systems for [URE3] detection and analysis.
    Brachmann A; Toombs JA; Ross ED
    Methods; 2006 May; 39(1):35-42. PubMed ID: 16762564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
    Boshuizen RS; Langeveld JP; Salmona M; Williams A; Meloen RH; Langedijk JP
    Anal Biochem; 2004 Oct; 333(2):372-80. PubMed ID: 15450815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient protein transformation protocol for introducing prions into yeast.
    Tanaka M; Weissman JS
    Methods Enzymol; 2006; 412():185-200. PubMed ID: 17046659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of yeast by infectious prion particles.
    King CY; Wang HL; Chang HY
    Methods; 2006 May; 39(1):68-71. PubMed ID: 16759879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of yeast prion aggregates in single living cells.
    Kawai-Noma S; Ayano S; Pack CG; Kinjo M; Yoshida M; Yasuda K; Taguchi H
    Genes Cells; 2006 Sep; 11(9):1085-96. PubMed ID: 16923127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the [PSI+] prion on rates of adaptation in yeast.
    Joseph SB; Kirkpatrick M
    J Evol Biol; 2008 May; 21(3):773-80. PubMed ID: 18312560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.